机构:[1]The Second Clinical School of Medicine, Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine-Zhuhai Hospital, Guangdong, China珠海院区广东省中医院[2]Guangdong Provincial Key Laboratory of Research on Emergency in Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China广东省中医院[3]Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China[4]Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China[5]Intensive Care Unit, Guangdong Second Provincial Hospital of Chinese Medicine, Guangzhou, China
Atherosclerosis (AS) is the main cause of ischemic cardiovascular, cerebrovascular and peripheral vascular diseases. Macrophage activity has been proven to play a critical role during the AS pathological process, which involves the adhesion, aggregation of mononuclear-macrophages, cell differentiation of M1/M2 macrophages as part of complex mechanisms occurring during lipid metabolism, apoptosis, autophagy, inflammation and immune reaction. Therefore, the development of effective AS treatments is likely to target macrophage activity. Certain herbal extracts (such as Salvia miltiorrhiza) have exhibited enormous potential for AS treatment in the past. Here, we aim to provide a summary on the current understanding of the type of action and the underlying target/pathway in macrophage regulation of certain herbal extracts used in Traditional Chinese Medicine for treatment of AS.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81603460]; Postdoctoral Science Foundation of ChinaChina Postdoctoral Science Foundation [2015 M581533]; Administration of Traditional Chinese Medicine of Guangdong Province [2018401981115]; Guangzhou Science Technology and Innovation Committee [201607010337]; Guangzhou University of Traditional Chinese Medicine High-level University Construction Project [A1-AFD018171Z11089]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|3 区医学
小类|3 区医学:研究与实验3 区药学
最新[2025]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区药学
JCR分区:
出版当年[2017]版:
Q2PHARMACOLOGY & PHARMACYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]The Second Clinical School of Medicine, Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine-Zhuhai Hospital, Guangdong, China
共同第一作者:
通讯作者:
通讯机构:[1]The Second Clinical School of Medicine, Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine-Zhuhai Hospital, Guangdong, China[3]Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China[4]Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China[*1]The Second Clinical School of Medicine, Guangzhou University of Chinese Medicine, Guangdong, China
推荐引用方式(GB/T 7714):
Xu Jian,Liu Yuntao,Zhao Zhen,et al.The role of traditional Chinese medicine in the treatment of atherosclerosis through the regulation of macrophage activity[J].BIOMEDICINE & PHARMACOTHERAPY.2019,118:doi:10.1016/j.biopha.2019.109375.
APA:
Xu, Jian,Liu, Yuntao,Zhao, Zhen,Zhao, Liyun,Wang, Dawei&Liu, Qing.(2019).The role of traditional Chinese medicine in the treatment of atherosclerosis through the regulation of macrophage activity.BIOMEDICINE & PHARMACOTHERAPY,118,
MLA:
Xu, Jian,et al."The role of traditional Chinese medicine in the treatment of atherosclerosis through the regulation of macrophage activity".BIOMEDICINE & PHARMACOTHERAPY 118.(2019)